Published in J Exp Clin Cancer Res on December 21, 2009
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell (2012) 4.51
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res (2011) 1.99
Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin (2010) 1.40
Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer (2011) 1.35
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer (2013) 1.25
Expression of transcription factors snail, slug, and twist in human bladder carcinoma. J Exp Clin Cancer Res (2010) 1.11
TWIST1 is expressed in colorectal carcinomas and predicts patient survival. PLoS One (2011) 1.06
T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol (2012) 1.02
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer (2011) 0.93
Twist-1 up-regulation in carcinoma correlates to poor survival. Int J Mol Sci (2014) 0.92
Inducible knockout of Twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting Twist1 as a preferential cancer target. Am J Pathol (2013) 0.86
Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression. World J Gastroenterol (2014) 0.81
Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells. Int J Mol Sci (2013) 0.79
Maximum standardized uptake value in (18)F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer. Mol Clin Oncol (2014) 0.77
TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance. J Cancer (2016) 0.76
Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma. Dis Markers (2016) 0.76
Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors. Virchows Arch (2013) 0.76
Multiple biological functions of Twist1 in various cancers. Oncotarget (2017) 0.75
Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis. Oncotarget (2016) 0.75
Expression and significance of GRHL2 in esophageal cancer. Onco Targets Ther (2017) 0.75
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38
TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer (1997) 5.80
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A (2007) 5.24
Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol (2002) 3.82
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res (2004) 3.64
Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res (2005) 3.32
Twist is a potential oncogene that inhibits apoptosis. Genes Dev (1999) 3.14
Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol (1991) 2.71
Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res (2006) 2.32
Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res (2003) 2.23
Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res (2005) 2.05
Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol (2004) 1.79
TWIST is expressed in human gliomas and promotes invasion. Neoplasia (2005) 1.70
High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol (2006) 1.63
Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res (1997) 1.47
Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology (2007) 1.45
Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol (1997) 1.43
Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology (1997) 1.37
Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol (2006) 1.36
Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol (2001) 1.25
Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol (2007) 1.22
Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer (2005) 1.10
Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep (2007) 1.03
A new twist on twist--modulation of the NF-kappa B pathway. Cell Cycle (2003) 0.95
alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma. J Surg Oncol (2007) 0.86
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol (2009) 5.56
Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res (2009) 2.61
Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell (2013) 2.23
A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med (2012) 2.20
Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res (2005) 2.05
Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol (2013) 1.79
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology (2006) 1.77
Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62
Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg (2003) 1.57
Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. Ann Surg Oncol (2011) 1.50
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med (2012) 1.47
Endosonographic detection of mediastinal lymph node metastasis in superficial carcinoma of the esophagus: assessment by type classification and histogram. J Gastroenterol (2004) 1.47
Delayed gastric emptying after pancreatoduodenectomy. J Surg Res (2011) 1.45
EGFR mutations and human papillomavirus in lung cancer. Lung Cancer (2012) 1.41
Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2002) 1.40
Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology (2008) 1.33
Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey. World J Surg (2010) 1.32
Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res (2003) 1.30
Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res (2002) 1.29
A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery (2004) 1.29
Thoracic endovascular aneurysm repair in Japan: Experience with fenestrated stent grafts in the treatment of distal arch aneurysms. J Vasc Surg (2008) 1.28
Early experience of immediate reconstruction using autologous free dermal fat graft after breast conservational surgery. J Plast Reconstr Aesthet Surg (2006) 1.28
A case of successful enteroscopic balloon dilation for late anastomotic stricture of choledochojejunostomy after living donor liver transplantation. Liver Transpl (2005) 1.27
Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg (2005) 1.26
Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery (2002) 1.24
Trans-Oral Video-Assisted Neck Surgery (TOVANS). A new transoral technique of endoscopic thyroidectomy with gasless premandible approach. Surg Endosc (2012) 1.22
Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem (2008) 1.22
Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma. J Asthma (2010) 1.18
Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 1.18
Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg (2008) 1.17
Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg (2006) 1.15
Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J (2013) 1.14
Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res (2008) 1.13
B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci (2011) 1.12
Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res (2002) 1.10
Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. J Surg Oncol (2011) 1.09
M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas (2013) 1.09
Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res (2004) 1.09
Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene (2002) 1.09
The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases. Ann Surg Oncol (2014) 1.08
Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg (2002) 1.08
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer (2013) 1.08
Lymph node micrometastasis and lymphatic mapping determined by reverse transcriptase-polymerase chain reaction in pN0 gastric carcinoma. Surgery (2002) 1.06
Subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) prevents postoperative delayed gastric emptying. J Surg Oncol (2010) 1.06
Clinical and pathologic evaluation of implanted free dermal fat grafts after breast cancer surgery: a retrospective analysis. Surgery (2011) 1.06
Surgery for hepatocellular carcinoma located in the caudate lobe. World J Surg (2009) 1.06
Mesothelin expression correlates with prolonged patient survival in gastric cancer. J Surg Oncol (2011) 1.05